U.S. Markets closed

Tauriga Sciences, Inc. (TAUG)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0260-0.0028 (-9.72%)
At close: 3:58PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0288
Open0.0285
BidN/A x N/A
AskN/A x N/A
Day's Range0.0260 - 0.0285
52 Week Range0.0153 - 0.0850
Volume202,107
Avg. Volume1,014,954
Market Cap4.301M
Beta (5Y Monthly)1.93
PE Ratio (TTM)N/A
EPS (TTM)-0.0330
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est0.10
  • Tauriga Sciences, Inc. Updates Shareholders on New York State's Determination to Allow the Sale of CBD Edibles in the Forms of Food & Drink
    GlobeNewswire

    Tauriga Sciences, Inc. Updates Shareholders on New York State's Determination to Allow the Sale of CBD Edibles in the Forms of Food & Drink

    The Company’s Flagship Brand Tauri-Gum™ is Fully Compliant With the New Rules Set Out This Week by New York State (“New York”)NEW YORK, NY, Oct. 28, 2020 (GLOBE NEWSWIRE) --  via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences company, with a proprietary line of functional “supplement” chewing gums (Flavors: Pomegranate, Blood Orange, Peach-Lemon, Pear Bellini, Mint, Black Currant) as well as two ongoing Biotechnology initiatives, has today updated its shareholders with respect to New York State’s updated rules and regulations – concerning the CBD Edibles Sector.  The State of New York has determined that it is allowable to sell CBD Infused Edible products in the forms of both food and drink (inclusive of chewing gum).  At no time can CBD be sold in products that contain either alcohol or tobacco.  Additionally: *  NO CBD Product Can be Sold if it Contains More than 0.3% (1/333rd by Composition) THC  *  No Individual Food or Beverage Product Can Contain More than 25mg of Hemp-Extracted Cannabinoids (“CBD” or “CBG”) per serving *  Food and Drink Infused with CBD and Other Hemp Extracts Must be Packaged by the Manufacturer *  Extracts can NOT be Added at the Retail LevelTauriga Sciences, Inc. is pleased to confirm that its flagship product line, branded as Tauri-Gum™, is fully compliant with all of the updated New York State rules and regulations that have been established this week. The Company believes that these new standards that have been set by New York will be helpful in driving greater market acceptance of ethical, high quality products such as Tauri-Gum™. ABOUT TAURIGA SCIENCES INC.Tauriga Sciences, Inc. (TAUG) is a revenue generating, diversified life sciences company, engaged in several major business activities and initiatives.  The company manufactures and distributes several proprietary retail products and product lines, mainly focused on the Cannabidiol (“CBD”) and Cannabigerol (“CBG”) Edibles market segment.  The main product line, branded as Tauri-Gum™, consists of a proprietary supplement chewing gum that is Kosher certified, Halal certified, and Vegan Formulated (CBD Infused Tauri-Gum™ Flavors: Mint, Blood Orange, Pomegranate), (CBG Infused Tauri-Gum™ Flavors: Peach-Lemon, Black Currant) & (Vitamin C + Zinc “Immune Booster” Tauri-Gum™ Flavor: Pear Bellini).  The Company’s commercialization strategy consists of a broad array of retail customers, distributors, and a fast-growing E-Commerce business segment (E-Commerce website: www.taurigum.com). Please visit our corporate website, for additional information, as well as inquiries, at http://www.tauriga.comComplementary to the Company’s retail business, are its two ongoing biotechnology initiatives.  The first one relates to the development of a Pharmaceutical grade version of Tauri-Gum™, for nausea regulation (specifically designed to help patients that are subjected to ongoing chemotherapy treatment). On March 18, 2020, the Company announced that it filed a provisional U.S. patent application covering its pharmaceutical grade version of Tauri-Gum™.  The Patent, filed with the U.S.P.T.O. is Titled “MEDICATED CBD COMPOSITIONS, METHODS OF MANUFACTURING, AND METHODS OF TREATMENT”. The second one relates to a collaboration agreement with Aegea Biotechnologies Inc. for the co-development of a rapid, multiplexed, Novel Coronavirus (COVID-19) test with superior sensitivity and selectivity.   On October 6, 2020, the Company announced that it has been approved to operate as a U.S. Government Vendor (CAGE CODE 8QXV4)On October 7, 2020 the Company disclosed a Strategic Alliance with Think BIG, LLC, Social Impact Startup Founded by CJ Wallace, Son of Christopher “The Notorious B.I.G.” Wallace.The Company is headquartered in New York City and operates a regional office in Barcelona, Spain.  In addition, the Company operates a full time E-Commerce fulfillment center located in LaGrangeville, New York.DISCLAIMER -- Forward-Looking StatementsThis press release contains certain “forward-looking statements” as defined by the Private Securities Litigation Reform Act of 1995 which represent management’s beliefs and assumptions concerning future events. These forward-looking statements are often indicated by using words such as “may,” “will,” “expects,” “anticipates,” believes, “hopes,” “believes,” or plans, and may include statements regarding corporate objectives as well as the attainment of certain corporate goals and milestones. Forward-looking statements are based on present circumstances and on management’s present beliefs with respect to events that have not occurred, that may not occur, or that may occur with different consequences or timing than those now assumed or anticipated. Actual results may differ materially from those expressed in  forward looking statements due to known and unknown risks and uncertainties, such as are not guarantees of general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to consummate successful acquisition and licensing transactions, fluctuations in exchange rates, and other factors over which Tauriga has little or no control. Many of these risks and uncertainties are discussed in greater detail in the “Risk Factors” section of Tauriga’s Form 10-K and other filings made from time to time with the Securities and Exchange Commission. Such forward-looking statements are made only as of the date of this release, and Tauriga assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. You should not place undue reliance on these forward-looking statements.Contact:Tauriga Sciences, Inc.555 Madison Avenue, 5th FloorNew York, NY  10022Chief Executive OfficerMr. Seth M. ShawEmail: sshaw@tauriga.comcell (917) 796 9926Instagram: @taurigumTwitter: @SethMShawCorp. Website:  www.tauriga.comE-Commerce Website:  www.taurigum.comPublic Relations:Tiger Global Managementinfo@TigerGMP.comwww.TigerGMP.com

  • Tauriga Sciences, Inc. to Commence 3rd Production Run of its CBD Infused Gum Drop Product – Branded as: Tauri-Gummies
    GlobeNewswire

    Tauriga Sciences, Inc. to Commence 3rd Production Run of its CBD Infused Gum Drop Product – Branded as: Tauri-Gummies

    This 3rd Production Run Will Incorporate Slight Modifications in Both Ingredient List & Label Design  NEW YORK, NY, Oct. 26, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire \-- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences company, with a proprietary line of functional “supplement” chewing gums (Flavors: Pomegranate, Blood Orange, Peach-Lemon, Pear Bellini, Mint, Black Currant) as well as two ongoing Biotechnology initiatives, today announced plans to commence a 3rd production run of its Cannabidiol (“CBD”) infused Gum Drop product, branded as: Tauri-Gummies™.  The Company is incorporating a slight re-formulation for this 3rd production run, to improve this highly popular CBD edibles product.  Since its late 2019 introduction, the Company’s Tauri-Gummies™ product has been very popular with its E-Commerce customers. This gum drop product is manufactured in the format of “1950s Nostalgic Style” and is also Vegan formulated (Gelatin Free).    The Company anticipates that this 3rd production run will be comprised of 3,000 – 5,000 Jars of Tauri-Gummies™.  Each Jar contains 24 gum drops, with each gum drop infused with 25mg of CBD isolate (600mg CBD per Jar).  The gum drops are manufactured in 4 distinct flavors: Cherry (Red), Orange (Orange), Lemon (Yellow), Lime (Green).      In other news, the Company continues to enhance the social media presence and brand awareness for its flagship brand: Tauri-Gum™.  The Company’s Tauri-Gum™ Instagram Page (@taurigum), now has more than 8,200 Followers. The Company plans to update shareholders, once the 10,000 Follower(s) threshold is surpassed.     ABOUT TAURIGA SCIENCES INC.  Tauriga Sciences, Inc. (TAUG) is a revenue generating, diversified life sciences company, engaged in several major business activities and initiatives.  The company manufactures and distributes several proprietary retail products and product lines, mainly focused on the Cannabidiol (“CBD”) and Cannabigerol (“CBG”) Edibles market segment.  The main product line, branded as Tauri-Gum™, consists of a proprietary supplement chewing gum that is Kosher certified, Halal certified, and Vegan Formulated (CBD Infused Tauri-Gum™ Flavors: Mint, Blood Orange, Pomegranate), (CBG Infused Tauri-Gum™ Flavors: Peach-Lemon, Black Currant) & (Vitamin C + Zinc “Immune Booster” Tauri-Gum™ Flavor: Pear Bellini).  The Company’s commercialization strategy consists of a broad array of retail customers, distributors, and a fast-growing E-Commerce business segment (E-Commerce website: www.taurigum.com). Please visit our corporate website, for additional information, as well as inquiries, at http://www.tauriga.com  Complementary to the Company’s retail business, are its two ongoing biotechnology initiatives.  The first one relates to the development of a Pharmaceutical grade version of Tauri-Gum™, for nausea regulation (specifically designed to help patients that are subjected to ongoing chemotherapy treatment). On March 18, 2020, the Company announced that it filed a provisional U.S. patent application covering its pharmaceutical grade version of Tauri-Gum™.  The Patent, filed with the U.S.P.T.O. is Titled “MEDICATED CBD COMPOSITIONS, METHODS OF MANUFACTURING, AND METHODS OF TREATMENT”. The second one relates to a collaboration agreement with Aegea Biotechnologies Inc. for the co-development of a rapid, multiplexed, Novel Coronavirus (COVID-19) test with superior sensitivity and selectivity.     On October 6, 2020, the Company announced that it has been approved to operate as a U.S. Government Vendor (CAGE CODE 8QXV4)  On October 7, 2020 the Company disclosed a Strategic Alliance with Think BIG, LLC, Social Impact Startup Founded by CJ Wallace, Son of Christopher “The Notorious B.I.G.” Wallace.  The Company is headquartered in New York City and operates a regional office in Barcelona, Spain.  In addition, the Company operates a full time E-Commerce fulfillment center located in LaGrangeville, New York.  DISCLAIMER -- Forward-Looking Statements  This press release contains certain “forward-looking statements” as defined by the Private Securities Litigation Reform Act of 1995 which represent management’s beliefs and assumptions concerning future events. These forward-looking statements are often indicated by using words such as “may,” “will,” “expects,” “anticipates,” believes, “hopes,” “believes,” or plans, and may include statements regarding corporate objectives as well as the attainment of certain corporate goals and milestones. Forward-looking statements are based on present circumstances and on management’s present beliefs with respect to events that have not occurred, that may not occur, or that may occur with different consequences or timing than those now assumed or anticipated. Actual results may differ materially from those expressed in  forward looking statements due to known and unknown risks and uncertainties, such as are not guarantees of general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to consummate successful acquisition and licensing transactions, fluctuations in exchange rates, and other factors over which Tauriga has little or no control. Many of these risks and uncertainties are discussed in greater detail in the “Risk Factors” section of Tauriga’s Form 10-K and other filings made from time to time with the Securities and Exchange Commission. Such forward-looking statements are made only as of the date of this release, and Tauriga assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. You should not place undue reliance on these forward-looking statements.    Contact:  Tauriga Sciences, Inc.555 Madison Avenue, 5th FloorNew York, NY  10022Chief Executive OfficerMr. Seth M. ShawEmail: sshaw@tauriga.comcell (917) 796 9926Instagram: @taurigumTwitter: @SethMShawCorp. Website:  www.tauriga.comE-Commerce Website:  www.taurigum.com        Public Relations:  Tiger Global Managementinfo@TigerGMP.comwww.TigerGMP.com

  • Tauri-Gum Product Line Now Available at Select Mobil and Shell Gas Station Convenience Store Locations
    GlobeNewswire

    Tauri-Gum Product Line Now Available at Select Mobil and Shell Gas Station Convenience Store Locations

    10_21 PR Tauri-Gum™ Product Line at Mobil Gas Station Location (Dutchess County, NY)NEW YORK, NY, Oct. 21, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire \-- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences company, with a proprietary line of functional “supplement” chewing gums (Flavors: Pomegranate, Blood Orange, Peach-Lemon, Pear Bellini, Mint, Black Currant) as well as two ongoing Biotechnology initiatives, today announced that the National product launch of its flagship brand, Tauri-Gum™, is continuing to realize important levels of progress.  The Company has recently updated and standardized its Tauri-Gum™ blister pack design, which has expedited its ability to procure both Purchase Orders as well as Distribution Agreements.  The Company’s Tauri-Gum™ product line is now available at select Mobil and Shell gas station convenience store locations.    The Company is working in partnership with its national distribution partner, Mr. Checkout Distributors (“Mr. Checkout”), to expand both its national and regional distribution capabilities.  In addition, the Company is continually expanding its retail customer base through the above-referenced efforts.   Lastly, the Company continues to report overall strength in its highest margin E-Commerce business segment.  This strength has largely been driven by the September 20, 2020 launch of its Rainbow Deluxe Sampler Pack (“Rainbow Pack”).  The Rainbow Pack is available exclusively on the Company’s E-Commerce Website (www.taurigum.com).Link to Purchase Tauri-Gum™ Rainbow Pack:https://taurigum.com/products/rainbow-deluxe-sampler-packABOUT TAURIGA SCIENCES INC.Tauriga Sciences, Inc. (TAUG) is a revenue generating, diversified life sciences company, engaged in several major business activities and initiatives.  The company manufactures and distributes several proprietary retail products and product lines, mainly focused on the Cannabidiol (“CBD”) and Cannabigerol (“CBG”) Edibles market segment.  The main product line, branded as Tauri-Gum™, consists of a proprietary supplement chewing gum that is Kosher certified, Halal certified, and Vegan Formulated (CBD Infused Tauri-Gum™ Flavors: Mint, Blood Orange, Pomegranate), (CBG Infused Tauri-Gum™ Flavors: Peach-Lemon, Black Currant) & (Vitamin C + Zinc “Immune Booster” Tauri-Gum™ Flavor: Pear Bellini).  The Company’s commercialization strategy consists of a broad array of retail customers, distributors, and a fast-growing E-Commerce business segment (E-Commerce website: www.taurigum.com). Please visit our corporate website, for additional information, as well as inquiries, at http://www.tauriga.comComplementary to the Company’s retail business, are its two ongoing biotechnology initiatives.  The first one relates to the development of a Pharmaceutical grade version of Tauri-Gum™, for nausea regulation (specifically designed to help patients that are subjected to ongoing chemotherapy treatment). On March 18, 2020, the Company announced that it filed a provisional U.S. patent application covering its pharmaceutical grade version of Tauri-Gum™.  The Patent, filed with the U.S.P.T.O. is Titled “MEDICATED CBD COMPOSITIONS, METHODS OF MANUFACTURING, AND METHODS OF TREATMENT”. The second one relates to a collaboration agreement with Aegea Biotechnologies Inc. for the co-development of a rapid, multiplexed, Novel Coronavirus (COVID-19) test with superior sensitivity and selectivity.   On October 6, 2020, the Company announced that it has been approved to operate as a U.S. Government Vendor (CAGE CODE 8QXV4)On October 7, 2020 the Company disclosed a Strategic Alliance with Think BIG, LLC, Social Impact Startup Founded by CJ Wallace, Son of Christopher “The Notorious B.I.G.” Wallace.The Company is headquartered in New York City and operates a regional office in Barcelona, Spain.  In addition, the Company operates a full time E-Commerce fulfillment center located in LaGrangeville, New York.DISCLAIMER -- Forward-Looking StatementsThis press release contains certain “forward-looking statements” as defined by the Private Securities Litigation Reform Act of 1995 which represent management’s beliefs and assumptions concerning future events. These forward-looking statements are often indicated by using words such as “may,” “will,” “expects,” “anticipates,” believes, “hopes,” “believes,” or plans, and may include statements regarding corporate objectives as well as the attainment of certain corporate goals and milestones. Forward-looking statements are based on present circumstances and on management’s present beliefs with respect to events that have not occurred, that may not occur, or that may occur with different consequences or timing than those now assumed or anticipated. Actual results may differ materially from those expressed in  forward looking statements due to known and unknown risks and uncertainties, such as are not guarantees of general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to consummate successful acquisition and licensing transactions, fluctuations in exchange rates, and other factors over which Tauriga has little or no control. Many of these risks and uncertainties are discussed in greater detail in the “Risk Factors” section of Tauriga’s Form 10-K and other filings made from time to time with the Securities and Exchange Commission. Such forward-looking statements are made only as of the date of this release, and Tauriga assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. You should not place undue reliance on these forward-looking statements.Contact:Tauriga Sciences, Inc.555 Madison Avenue, 5th FloorNew York, NY  10022Chief Executive OfficerMr. Seth M. ShawEmail: sshaw@tauriga.comcell (917) 796 9926Instagram: @taurigumTwitter: @SethMShawCorp. Website:  www.tauriga.comE-Commerce Website:  www.taurigum.comAttachment * 10_21 PR